Trials involving emerging cell therapies in developing markets place unusual demands on the supply chain

The Challenge:A new United States-based biopharma working on its first cell therapy-based treatment had expanded the scope of their trial and extended its patient pool to include a patient in Beijing, China. Learn how they addressed the challenges of:

  • Identifying a packaging / shipper solution
  • Navigating the regulatory environment for product import
  • Providing final mile white glove delivery service